Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 4/20 | 0.61 |
| ▸ | CTSS | P25774 | 3/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | PREP | P48147 | 1/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.48 |
| ▸ | CTSL | P07711 | 2/20 | 0.48 |
| ▸ | CTSB | P07858 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | SDCBP | O00560 | 1/20 | 0.43 |
| ▸ | SDC2 | P34741 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29674710 | 1.00 | CTSK (0.61) | CTSKCTSSCA2CA1CA7 | |
| SCHEMBL59323 | 1.00 | CTSK (0.61) | CTSKCTSSCA2CA1CA7 | |
| SCHEMBL467994 | 1.00 | CTSK (0.61) | CTSKCTSSCA2CA1CA7 | |
| SCHEMBL28058549 | 0.98 | CTSK (0.59) | CTSKCTSSCA2CA1CA7 | |
| Ammonia Solution, Strong SCHEMBL28313812 | 0.98 | CTSK (0.59) | CTSKCTSSCA2CA1CA7 | |
| Fluoride SCHEMBL7360444 | 0.98 | CTSK (0.59) | CTSKCTSSCA2CA1CA7 | |
| Fluoride SCHEMBL7360449 | 0.98 | CTSK (0.59) | CTSKCTSSCA2CA1CA7 | |
| SCHEMBL22371979 | 0.93 | CTSK (0.63) | CTSKCTSSCA2CA1CA7 | |
| SCHEMBL7345607 | 0.93 | CTSK (0.63) | CTSKCTSSCA2CA1CA7 | |
| SCHEMBL22371977 | 0.93 | CTSK (0.63) | CTSKCTSSCA2CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 925 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025019172-A1 | ANTIMICROBIAL EXTRACTANT FORMED FROM COPPER-CONTAINING SOURCE | CORNING INCORPORATED (US) | 2025-01-23 | — | — | WO | claimed |
| CN-114907231-B | Indene chiral spiro fluorescent compound, and preparation method and application thereof | 杭州师范大学 | 2024-02-23 | — | — | CN | claimed |
| WO-2024017221-A1 | SYNTHESIS METHOD FOR α-AZIDO KETONE CONTAINING TERTIARY STEREOCENTER | 常州大学 | 2024-01-25 | — | — | WO | claimed |
| CN-112321627-B | Axis chiral arylethynyl silane compound and preparation method thereof | 杭州师范大学 | 2023-09-01 | — | — | CN | claimed |
| CN-115108937-B | Synthesis method of alpha-azido ketone containing three-level stereo center | 常州大学 | 2023-08-22 | — | — | CN | claimed |
| CN-115108937-A | Synthesis method of alpha-azidoketone containing three-level stereocenter | 常州大学 | 2022-09-27 | — | — | CN | claimed |
| CN-114907231-A | Indene chiral spiro fluorescent compound and preparation method and application thereof | 杭州师范大学 | 2022-08-16 | — | — | CN | claimed |
| CN-114478627-A | Allylation monophosphine ligand and preparation method thereof | 湖北大学 | 2022-05-13 | — | — | CN | claimed |
| EP-3988538-A1 | MODIFIED HYDROPHOBIC AUXILIARY MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | Zhejiang Zhida Pharmaceutical Co., Ltd. (CN) | 2022-04-27 | — | — | EP | claimed |
| US-20220111055-A1 | MODIFIED HYDROPHOBIC EXCIPIENT AND PREPARATION METHOD THEREOF | ZHEJIANG ZHIDA PHARMACEUTICAL CO., LTD. (CN) | 2022-04-14 | — | — | US | claimed |
| US-20100290951-A1 | SURFACE-BASED AMMONIUM ION SENSOR: AN ELECTRODE DERIVATIZED WITH A SELF-ASSEMBLED MONOLAYER | WORCESTER POLYTECHNIC INSITUTE (US) | 2010-11-18 | — | — | US | claimed |
| WO-2010103486-A1 | PYRAZOLO[1,5-A]-1,3,5-TRIAZINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-09-16 | — | — | WO | claimed |
| EP-1794172-B1 | ANTIVIRAL 4'-AZIDO-NUCLEOSIDES | HOFFMANN LA ROCHE (CH) | 2009-07-15 | — | — | EP | claimed |
| US-7265140-B2 | Acyloxymethylcarbamate prodrugs of oxazolidinones | PFIZER INC (US) | 2007-09-04 | — | — | US | claimed |
| EP-1794172-A1 | ANTIVIRAL 4'-AZIDO-NUCLEOSIDES | F.HOFFMANN-LA ROCHE AG (CH) | 2007-06-13 | — | — | EP | claimed |
| EP-1668005-B1 | ACYLOXYMETHYLCARBAMATE PRODRUGS OF OXAZOLIDINONES | PHARMACIA & UPJOHN CO LLC (US) | 2007-02-14 | — | — | EP | claimed |
| EP-1668005-A1 | ACYLOXYMETHYLCARBAMATE PRODRUGS OF OXAZOLIDINONES | Pharmacia & Upjohn Company LLC (US) | 2006-06-14 | — | — | EP | claimed |
| WO-2006021341-A1 | ANTIVIRAL 4’-AZIDO-NUCLEOSIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2006-03-02 | — | — | WO | claimed |
| US-20050267104-A1 | E.g., ({[Acetyl({(5R)-3-[4-(1,1-dioxidotetrahydro-2H-thiopyran4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl}-methyl)amino]carbonyl}oxymethyl acetate; these compounds have potent activity with excellent oral bioavailability against Gram-positive and Gram-negative bacteria | PHARMACIA & UPJOHN COMPANY LLC | 2005-12-01 | — | — | US | claimed |
| WO-2005028473-A1 | ACYLOXYMETHYLCARBAMATE PRODRUGS OF OXAZOLIDINONES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2005-03-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050267104-A1 | E.g., ({[Acetyl({(5R)-3-[4-(1,1-dioxidotetrahydro-2H-thiopyran4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl}-methyl)amino]carbonyl}oxymethyl acetate; these compounds have potent activity with excellent oral bioavailability against Gram-positive and Gram-negative bacteria | HDAC3, HDAC1, OGA | CTSK 1988/4885CTSS 3028/4885CA2 1189/4885 |
| US-20100290951-A1 | SURFACE-BASED AMMONIUM ION SENSOR: AN ELECTRODE DERIVATIZED WITH A SELF-ASSEMBLED MONOLAYER | DNMT3A, ACMSD, CD4 | CTSK 4373/4885CTSS 4833/4885CA2 114/4885 |
| US-20220111055-A1 | MODIFIED HYDROPHOBIC EXCIPIENT AND PREPARATION METHOD THEREOF | CETP, SLC43A1, SLC27A1 | CTSK 4188/4885CTSS 3839/4885CA2 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.